Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases

被引：23

作者：

Wang, Gary T. ^{[1
]}

Mantei, Robert A. ^{[1
]}

Hubbard, Robert D. ^{[1
]}

Wilsbacher, Julie L. ^{[1
]}

Zhang, Qian ^{[1
]}

Tucker, Lora ^{[1
]}

Hu, Xiaoming ^{[1
]}

Kovar, Peter ^{[1
]}

Johnson, Eric F. ^{[1
]}

Osterling, Donald J. ^{[1
]}

Bouska, Jennifer ^{[1
]}

Wang, Jieyi ^{[1
]}

Davidsen, Steven K. ^{[1
]}

Bell, Randy L. ^{[1
]}

Sheppard, George S. ^{[1
]}

机构：

[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 20期

关键词：

Multi-targeted kinase inhibitors; IGF1R; EGFR; ErbB2; ACQUIRED-RESISTANCE; ANTITUMOR-ACTIVITY; CANCER-CELLS; POTENT; DISCOVERY; LAPATINIB; ANTIBODY; BREAST;

D O I：

10.1016/j.bmcl.2010.08.052

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This Letter describes the lead discovery, optimization, and biological characterization of a series of substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as potent inhibitors of IGF1R, EGFR, and ErbB2. The leading compound 11 showed an IGF1R IC50 of 12 nM, an EGFR (L858R) IC50 of 31 nM, and an ErbB2 IC50 of 11 nM, potent activity in cellular functional and anti-proliferation assays, as well as activity in an in vivo pharmacodynamic assay. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：6067 / 6071

页数：5

共 50 条

[21] Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors
Buchanan, John L.
Newcomb, John R.
Carney, David P.
Chaffee, Stuart C.
Chai, Lilly
Cupples, Rod
Epstein, Linda F.
Gallant, Paul
Gu, Yan
Harmange, Jean-Christophe
Hodge, Kathy
Houk, Brett E.
Huang, Xin
Jona, Janan
Joseph, Smriti
Jun, H. Toni
Kumar, Rakesh
Li, Chun
Lu, John
Menges, Tom
Morrison, Michael J.
Novak, Perry M.
van der Plas, Simon
Radinsky, Robert
Rose, Paul E.
Sawant, Satin
Sun, Ji-Rong
Surapaneni, Sekhar
Turci, Susan M.
Xu, Keyang
Yanez, Evelyn
Zhao, Huilin
Zhu, Xiaotian
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2394 - 2399
[22] Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
Subbiah, Vivek
Naing, Aung
Brown, Robert E.
Chen, Helen
Doyle, Laurence
LoRusso, Patricia
Benjamin, Robert
Anderson, Pete
Kurzrock, Razelle
PLOS ONE, 2011, 6 (04):
[23] INSULIN-LIKE GROWTH FACTOR RECEPTOR 1(IGF1R) AND EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION AND EXPRESSION IN SURGICALLY RESECTED NSCLC
Ludovini, Vienna
Flacco, Antonella
Bianconi, Fortunato
Tofanetti, Francesca Romana
Ragusa, Mark
Vannucci, Jacopo
Bellezza, Guido
Chiari, Rita
Minotti, Vincenzo
Pistola, Lorenza
Siggillino, Annamaria
Baldelli, Elisa
Puma, Francesco
Crino, Lucio
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1062 - S1063
[24] The Expression of Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Early Breast Cancer
Spears, M.
Cunningham, C. A.
Thomas, J. J.
Kerr, G. R.
Jack, W. L.
Campbell, F. M.
McKay, L.
Kunkler, I. H.
Cameron, D. A.
Chetty, U.
Bartlett, J. M. S.
CANCER RESEARCH, 2009, 69 (24) : 634S - 634S
[25] Discovery and optimization of imidazo[1,2-α]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)
Emmitte, Kyle A.
Wilson, Brian J.
Baum, Erich W.
Emerson, Holly K.
Kuntz, Kevin W.
Nailor, Kristen E.
Salovich, James M.
Smith, Stephon C.
Cheung, Mui
Gerding, Roseanne M.
Stevens, Kirk L.
Uehling, David E.
Mook, Robert A., Jr.
Moorthy, Ganesh S.
Dickerson, Scott H.
Hassell, Anne M.
Leesnitzer, M. Anthony
Shewchuk, Lisa M.
Groy, Arthur
Rowand, Jason L.
Anderson, Kelly
Atkins, Charity L.
Yang, Jingsong
Sabbatini, Peter
Kumar, Rakesh
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 1004 - 1008
[26] The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs)
Pantaleo, Maria A.
Astolfi, Annalisa
Nannini, Margherita
Biasco, Guido
JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
[27] Insulin-like Growth Factor 1 Receptor (IGF1R) - A novel therapeutic target in chronic lymphocytic leukemia
Yaktapour, N.
Uebelhart, R.
Schueler, J.
Dierks, C.
Burger, M.
Pfeifer, D.
Jumaa, H.
Veelken, H.
Brummer, T.
Zirlik, K.
ONKOLOGIE, 2013, 36 : 192 - 192
[28] The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs)
Maria A Pantaleo
Annalisa Astolfi
Margherita Nannini
Guido Biasco
Journal of Translational Medicine, 8
[29] Mutations in insulin-like growth factor receptor 1 gene (IGF1R) resulting in intrauterine and postnatal growth retardation
Leal, Andrea de Castro
Machado Canton, Ana Pinheiro
Montenegro, Luciana Ribeiro
Coutinho, Debora Cabral
Prado Arnhold, Ivo Jorge
de Lima Jorge, Alexander Augusto
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2011, 55 (08) : 541 - 549
[30] Association of the GAA1013→GAG polymorphism of the insulin-like growth factor-1 receptor (IGF1R) gene with premature pubarche
Roldan, Maria Belen
White, Carlie
Witchel, Selma Feldman
FERTILITY AND STERILITY, 2007, 88 (02) : 410 - 417

← 1 2 3 4 5 →